Development of nanostructures in the diagnosis of drug hypersensitivity reactions

Current Opinion in Allergy and Clinical Immunology

Volumn 16, Issue 4, 2016, Pages 300-307

  Mayorga, Cristobalina ^a   Perez Inestrosa, Ezequiel ^b,c   Molina, Noemi ^b,c   Montañez, Maria I ^a,c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c Institute of Biomedical Research in Malaga and BIONAND Nanomedicine Platform   (Spain)

Author keywords

beta lactam allergy; dendrimers; immunoglobulin E; in vitro techniques; nanoparticles

Indexed keywords

DENDRIMER; EPITOPE; IMMUNOGLOBULIN E; NANOMATERIAL; NANOPARTICLE; ALLERGEN; HAPTEN;

BIOMEDICINE; DRUG HYPERSENSITIVITY; DRUG HYPERSENSITIVITY REACTION; HUMAN; HYBRIDIZATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOASSAY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; IMMUNOLOGY; METABOLISM; MINIATURIZATION; PROCEDURES; SENSITIVITY AND SPECIFICITY; TRENDS; UTILIZATION;

ALLERGENS; ANIMALS; DRUG HYPERSENSITIVITY; EPITOPES; HAPTENS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN E; MINIATURIZATION; NANOPARTICLES; NANOSTRUCTURES; SENSITIVITY AND SPECIFICITY;

EID: 84973304702     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000282     Document Type: Review

References (67)

1. Thong BYH, Tan T-C. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 2011; 71:684-700.
2. Brockow K, Garvey LH, Aberer W, et al. Skin test concentrations for systemically administered drugs-an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy 2013; 68:702-712.
3. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58:854-863.
4. Torres MJ, Blanca M, Fernandez J, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-972.
5. Romano A, Torres MJ, Castells M, et al. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 2011; 127:S67-S73.
6. Brockow K, Romano A, Aberer W, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - A European multicenter study. Allergy 2009; 64:234-241.
7. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64:183-193.
8. Kowalski ML, Asero R, Bavbek S, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal antiinflammatory drugs. Allergy 2013; 68:1219-1232.
9. Ebo DG, Sainte-Laudy J, Bridts CH, et al. Flow-assisted allergy diagnosis: current applications and future perspectives. Allergy 2006; 61:1028-1039.
10. Demoly P, Adkinson NF, Brockow K, et al. International consensus on drug allergy. Allergy 2014; 69:420-437.
11. Blanca M, Mayorga C, Perez E, et al. Determination of IgE antibodies to the benzyl penicilloyl determinant. A comparison between poly-L-lysine and human serum albumin as carriers. J Immunol Methods 1992; 153:99-105.
12. Moreno F, Blanca M, Mayorga C, et al. Studies of the specificities of IgE antibodies found in sera from subjects with allergic reactions to penicillins. Int Arch Allergy Immunol 1995; 108:74-81.
13. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005; 19:311-330.
14. Vultaggio A, Matucci A, Virgili G, et al. Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies. Clin Exp Allergy 2009; 39:838-844.
15. Ebo DG, Leysen J, Mayorga C, et al. The in vitro diagnosis of drug allergy: status and perspectives. Allergy 2011; 66:1275-1286.
16. Fontaine C, Mayorga C, Bousquet PJ, et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 2007; 62:47-52.
17. Torres MJ, Romano A, Mayorga C, et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 2001; 56:850-856.
18. Garcia JJ, Blanca M, Moreno F, et al. Determination of IgE antibodies to the benzylpenicilloyl determinant: a comparison of the sensitivity and specificity of three radio allergo sorbent test methods. J Clin Lab Anal 1997; 11:251-257.
19. Montanez MI, Najera F, Mayorga C, et al. Recognition of multiepitope dendrimeric antigens by human immunoglobulin E. Nanomedicine 2015; 11:579-588.
20. Min Y, Caster JM, Eblan MJ, et al. Clinical translation of nanomedicine. Chem Rev 2015; 115:11147-11190.
21. Domb AJ, Tabata Y, Ravi Kumar MNV, et al., editors. Nanoparticles for pharmaceutical applications, 1st ed. California: American Scientific Publishers; 2007.
22. Torchilin VP, editor. Nanoparticulates as drug carriers, 1st ed. London: Imperial Collage Press; 2006.
23. Chen G, Roy I, Yang C, et al. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy. Chem Rev 2016; 116:2826-2885.
24. Sessa G, Weissmann G. Phospholipid spherules (liposomes) as a model for biological membranes. J Lipid Res 1968; 9:310-318.
25. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013; 65:36-48.
26. Wang H, Huang Q, Chang H, et al. Stimuli-responsive dendrimers in drug delivery. Biomater Sci 2016; 4:375-390.
27. Kannan RM, Nance E, Kannan S, et al. Emerging concepts in dendrimerbased nanomedicine: from design principles to clinical applications. J Intern Med 2014; 276:579-617.
28. Mignani S, El Kazzouli S, Bousmina M, et al. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview. Adv Drug Deliv Rev 2013; 65:1316-1330.
29. Carlmark A, Malmstrom E, Malkoch M. Dendritic architectures based on bis-MPA: functional polymeric scaffolds for application-driven research. Chem Soc Rev 2013; 42:5858-5879.
30. Min Y, Caster JM, Eblan MJ, et al. Clinical translation of nanomedicine. Chem Rev 2015; 115:11147-11190.
31. Kossovsky N, Conway D, Kossowsky R, et al. Novel anti-silicone surfaceassociated antigen antibodies (anti-SSAA(x)) may help differentiate symptomatic patients with silicone breast implants from patients with classical rheumatological disease. Curr Top Microbiol Immunol 1996; 210:327-336.
32. Singh M, Srivastava I. Advances in vaccine adjuvants for infectious diseases. Curr HIV Res 2003; 1:309-320.
33. Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, et al. Nanoparticles and the immune system. Endocrinology 2010; 151:458-465.
34. Yen HJ, Hsu SH, Tsai CL. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 2009; 5:1553-1561.
35. Niikura K, Matsunaga T, Suzuki T, et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano 2013; 7:3926-3938.
36. Moyano DF, Goldsmith M, Solfiell DJ, et al. Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc 2012; 134:3965-3967.
37. Fernandez TD, Pearson JR, Leal MP, et al. Intracellular accumulation and immunological properties of fluorescent gold nanoclusters in human dendritic cells. Biomaterials 2015; 43:1-12.
38. Sharp FA, Ruane D, Claass B, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A 2009; 106:870-875.
39. Fahmy TM, Demento SL, Caplan MJ, et al. Design opportunities for actively targeted nanoparticle vaccines. Nanomedicine (Lond) 2008; 3:343-355.
40. Lefebvre DE, Pearce B, Fine JH, et al. In vitro enhancement of mouse T helper 2 cell sensitization to ovalbumin allergen by carbon black nanoparticles. Toxicol Sci 2014; 138:322-332.
41. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J 2015; 8:17.
42. Inoue K, Takano H, Yanagisawa R, et al. Effects of nano particles on antigenrelated airway inflammation in mice. Respir Res 2005; 6:106.
43. Inoue K, Koike E, Yanagisawa R, et al. Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicol Appl Pharmacol 2009; 237:306-316.
44. Shahbazi MA, Fernandez TD, Makila EM, et al. Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms. Biomaterials 2014; 35:9224-9235.
45. Le Guevel X, Perez Perrino M, Fernandez TD, et al. Multivalent glycosylation of fluorescent gold nanoclusters promotes increased human dendritic cell targeting via multiple endocytic pathways. ACS Appl Mater Interfaces 2015; 7:20945-20956.
46. Balenga NA, Zahedifard F, Weiss R, et al. Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergy. J Biotechnol 2006; 124:602-614.
47. Martin SF, Esser PR, Schmucker S, et al. T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Sci 2010; 67:4171-4184.
48. Hong S, Leroueil PR, Majoros IJ, et al. The binding avidity of a nanoparticlebased multivalent targeted drug delivery platform. Chem Biol 2007; 14:107-115.
49. Lundqvist M, Stigler J, Elia G, et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008; 105:14265-14270.
50. Weissleder R, Kelly K, Sun EY, et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005; 23:1418-1423.
51. Ibraimi F, Kriz D, Lu M, et al. Rapid one-step whole blood C-reactive protein magnetic permeability immunoassay with monoclonal antibody conjugated nanoparticles as superparamagnetic labels and enhanced sedimentation. Anal Bioanal Chem 2006; 384:651-657.
52. Cretich M, Di Carlo G, Giudici C, et al. Detection of allergen specific immunoglobulins by microarrays coupled to microfluidics. Proteomics 2009; 9:2098-2107.
53. Cesaro-Tadic S, Dernick G, Juncker D, et al. High-sensitivity miniaturized immunoassays for tumor necrosis factor alpha using microfluidic systems. Lab Chip 2004; 4:563-569.
54. Teste B, Kanoufi F, Descroix S, et al. Kinetic analyses and performance of a colloidal magnetic nanoparticle based immunoassay dedicated to allergy diagnosis. Anal Bioanal Chem 2011; 400:3395-3407.
55. Teste B, Malloggi F, Siaugue JM, et al. Microchip integrating magnetic nanoparticles for allergy diagnosis. Lab Chip 2011; 11:4207-4213.
56. Kim S, Lee J, Lee SJ, et al. Ultra-sensitive detection of IgE using biofunctionalized nanoparticle-enhanced SPR. Talanta 2010; 81:1755-1759.
57. Chinnasamy T, Segerink LI, Nystrand M, et al. A lateral flow paper microarray for rapid allergy point of care diagnostics. Analyst 2014; 139:2348-2354.
58. Montanez MI, Perez-Inestrosa E, Suau R, et al. Dendrimerized cellulose as a scaffold for artificial antigens with applications in drug allergy diagnosis. Biomacromolecules 2008; 9:1461-1466.
59. Montanez MI, Mayorga C, Torres MJ, et al. Dendrimeric antigens. New approaches towards detection of IgE-mediated drug allergy reactions dendrimers in biomedical applications. The Royal Society of Chemistry; 2013; 84-98.
60. Montañez MI, Hed Y, Utsel S, et al. Bifunctional dendronized cellulose surfaces as biosensors. Biomacromolecules 2011; 12:2114-2125.
61. Montañez MI, Najera F, Perez-Inestrosa E. NMR studies and molecular dynamic simulation of synthetic dendrimeric-antigens. Polymers 2011; 3:1533-1553.
62. Sanchez-Sancho F, Perez-Inestrosa E, Suau R, et al. Dendrimers as carrier protein mimetics for IgE antibody recognition. Synthesis and characterization of densely penicilloylated dendrimers. Bioconjug Chem 2002; 13:647-653.
63. Montanez MI, Mayorga C, Torres MJ, et al. Methodologies to anchor dendrimeric nanoconjugates to solid phase: toward an efficient in vitro detection of allergy to beta-lactam antibiotics. Nanomedicine 2011; 7:682-685.
64. Ruiz-Sanchez AJ, Montanez MI, Mayorga C, et al. Dendrimer-modified solid supports: nanostructured materials with potential drug allergy diagnostic applications. Curr Med Chem 2012; 19:4942-4954.
65. Vida Y, Montanez MI, Collado D, et al. Dendrimeric antigen-silica particle composites: an innovative approach for IgE quantification. J Mater Chem B 2013; 1:3044-3050.
66. Soler M, Mesa-Antunez P, Estevez MC, et al. Highly sensitive dendrimerbased nanoplasmonic biosensor for drug allergy diagnosis. Biosens Bioelectron 2015; 66:115-123.
67. Ariza A, Barrionuevo E, Mayorga C, et al. IgE to penicillins with different specificities can be identified by a multiepitope macromolecule: bihaptenic penicillinstructuresandIgEspecificities. JImmunolMethods2014;406:43-50.